ALXN
Alexion Pharmaceuticals
ALXN
ALXN
Delisted
ALXN was delisted on the 20th of July, 2021.
521 hedge funds and large institutions have $31.8B invested in Alexion Pharmaceuticals in 2014 Q3 according to their latest regulatory filings, with 55 funds opening new positions, 183 increasing their positions, 209 reducing their positions, and 48 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
13% less funds holding in top 10
Funds holding in top 10: 15 → 13 (-2)
22% less call options, than puts
Call options by funds: $126M | Put options by funds: $160M
Holders
521
Holding in Top 10
13
Calls
$126M
Puts
$160M
Top Buyers
| 1 | +$399M | |
| 2 | +$397M | |
| 3 | +$81.9M | |
| 4 |
American Century Companies
Kansas City,
Missouri
|
+$81.1M |
| 5 |
Jennison Associates
New York
|
+$38.9M |
Top Sellers
| 1 | -$219M | |
| 2 | -$125M | |
| 3 | -$121M | |
| 4 |
Millennium Management
New York
|
-$120M |
| 5 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
-$72.2M |